Inventor
SCHNEIDER BIRGITT
DE17 patents
⚠️ This page may combine multiple inventors who share the name “SCHNEIDER BIRGITT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JENAPHARM GMBH
6 patentsUS6436917B1Aug 20, 2002
Non-estrogenic estradiol derivative compounds with anti-oxidative activity
JENAPHARM GMBH25 citations92
US6388109B1May 14, 2002
14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds
JENAPHARM GMBH53 citations91
US6080735AJun 27, 2000
Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
JENAPHARM GMBH20 citations91
US5705495AJan 6, 1998
Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
JENAPHARM GMBH25 citations90
US6569844B1May 27, 2003
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives
JENAPHARM GMBH8 citations72
US6534490B1Mar 18, 2003
Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds
JENAPHARM GMBH0 citations40
SCHERING AG
6 patentsUS6841548B2Jan 11, 2005
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives
SCHERING AG14 citations82
US6825182B2Nov 30, 2004
17α-fluoroalkyl-11β-benzaldoxime steroids, process for their production, pharmaceutical preparations that contain these steroids as well as their use for the production of pharmaceutical agents
SCHERING AG17 citations82
US6583130B1Jun 24, 2003
C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
SCHERING AG18 citations82
US7419972B2Sep 2, 2008
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
SCHERING AG2 citations58
US7199115B2Apr 3, 2007
17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
SCHERING AG0 citations51
US7435757B2Oct 14, 2008
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
SCHERING AG0 citations48
BAYER SCHERING PHARMA AG
4 patentsUS7534780B2May 19, 2009
Estradiol prodrugs
BAYER SCHERING PHARMA AG59 citations97
US7550451B2Jun 23, 2009
Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy
BAYER SCHERING PHARMA AG10 citations83
US7732493B2Jun 8, 2010
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
BAYER SCHERING PHARMA AG0 citations48
US7388003B2Jun 17, 2008
Δ15-D-Homosteroids with androgenic action
BAYER SCHERING PHARMA AG0 citations41